These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16404421)

  • 21. Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells.
    Frosi Y; Ramlan SR; Brown CJ
    J Vis Exp; 2020 May; (159):. PubMed ID: 32421011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leucine stimulates protein synthesis in skeletal muscle of neonatal pigs by enhancing mTORC1 activation.
    Suryawan A; Jeyapalan AS; Orellana RA; Wilson FA; Nguyen HV; Davis TA
    Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E868-75. PubMed ID: 18682538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status and challenges associated with targeting mTOR for cancer therapy.
    Dowling RJ; Pollak M; Sonenberg N
    BioDrugs; 2009; 23(2):77-91. PubMed ID: 19489650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.
    Sun SY; Rosenberg LM; Wang X; Zhou Z; Yue P; Fu H; Khuri FR
    Cancer Res; 2005 Aug; 65(16):7052-8. PubMed ID: 16103051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity of global translation to mTOR inhibition in REN cells depends on the equilibrium between eIF4E and 4E-BP1.
    Grosso S; Pesce E; Brina D; Beugnet A; Loreni F; Biffo S
    PLoS One; 2011; 6(12):e29136. PubMed ID: 22216185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth.
    Gibbons JJ; Abraham RT; Yu K
    Semin Oncol; 2009 Dec; 36 Suppl 3():S3-S17. PubMed ID: 19963098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular cross-talk between MEK1/2 and mTOR signaling during recovery of 293 cells from hypertonic stress.
    Naegele S; Morley SJ
    J Biol Chem; 2004 Oct; 279(44):46023-34. PubMed ID: 15292274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caerulein-induced acute pancreatitis inhibits protein synthesis through effects on eIF2B and eIF4F.
    Sans MD; DiMagno MJ; D'Alecy LG; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G517-28. PubMed ID: 12773302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
    Shi F; Len Y; Gong Y; Shi R; Yang X; Naren D; Yan T
    PLoS One; 2015; 10(8):e0136746. PubMed ID: 26317515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rapid activation of protein synthesis by growth hormone requires signaling through mTOR.
    Hayashi AA; Proud CG
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1647-55. PubMed ID: 17284572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance exercise increases muscle protein synthesis and translation of eukaryotic initiation factor 2Bepsilon mRNA in a mammalian target of rapamycin-dependent manner.
    Kubica N; Bolster DR; Farrell PA; Kimball SR; Jefferson LS
    J Biol Chem; 2005 Mar; 280(9):7570-80. PubMed ID: 15591312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel translational control in Arc-dependent long term potentiation consolidation in vivo.
    Panja D; Dagyte G; Bidinosti M; Wibrand K; Kristiansen AM; Sonenberg N; Bramham CR
    J Biol Chem; 2009 Nov; 284(46):31498-511. PubMed ID: 19755425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular target of rapamycin (mTOR) as a therapeutic target against cancer.
    Mita MM; Mita A; Rowinsky EK
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S169-77. PubMed ID: 14508096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetate regulates milk fat synthesis through the mammalian target of rapamycin/eukaryotic initiation factor 4E signaling pathway in bovine mammary epithelial cells.
    Zhao Y; Guo X; Yan S; Shi B; Sheng R
    J Dairy Sci; 2021 Jan; 104(1):337-345. PubMed ID: 33189285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammalian target of rapamycin: a new molecular target for breast cancer.
    Mita MM; Mita A; Rowinsky EK
    Clin Breast Cancer; 2003 Jun; 4(2):126-37. PubMed ID: 12864941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.
    Hidalgo M; Rowinsky EK
    Oncogene; 2000 Dec; 19(56):6680-6. PubMed ID: 11426655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells.
    Hafizi S; Wang X; Chester AH; Yacoub MH; Proud CG
    Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1232-8. PubMed ID: 15317677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. eIF4E3 forms an active eIF4F complex during stresses (eIF4FS) targeting mTOR and re-programs the translatome.
    Weiss B; Allen GE; Kloehn J; Abid K; Jaquier-Gubler P; Curran JA
    Nucleic Acids Res; 2021 May; 49(9):5159-5176. PubMed ID: 33893802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RhoE inhibits 4E-BP1 phosphorylation and eIF4E function impairing cap-dependent translation.
    Villalonga P; Fernández de Mattos S; Ridley AJ
    J Biol Chem; 2009 Dec; 284(51):35287-96. PubMed ID: 19850923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids.
    Shen WH; Boyle DW; Wisniowski P; Bade A; Liechty EA
    J Endocrinol; 2005 May; 185(2):275-89. PubMed ID: 15845920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.